The increase in price target by Truist Securities suggests an improved outlook on Globus Medical's stock value, which could lead to increased investor confidence and a potential short-term rise in the stock price. However, the Hold rating indicates that the analyst does not see significant momentum or changes in the company's fundamentals that would justify an upgrade to Buy.